428 related articles for article (PubMed ID: 37686080)
21. Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.
Calabresi P; Mechelli A; Natale G; Volpicelli-Daley L; Di Lazzaro G; Ghiglieri V
Cell Death Dis; 2023 Mar; 14(3):176. PubMed ID: 36859484
[TBL] [Abstract][Full Text] [Related]
22. Synucleinopathies: Intrinsic and Extrinsic Factors.
Lomeli-Lepe AK; Castañeda-Cabral JL; López-Pérez SJ
Cell Biochem Biophys; 2023 Sep; 81(3):427-442. PubMed ID: 37526884
[TBL] [Abstract][Full Text] [Related]
23. Influence of Cholesterol on the Membrane Binding and Conformation of α-Synuclein.
Qi Z; Wan M; Zhang J; Li Z
J Phys Chem B; 2023 Mar; 127(9):1956-1964. PubMed ID: 36812386
[TBL] [Abstract][Full Text] [Related]
24. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease.
Kasen A; Houck C; Burmeister AR; Sha Q; Brundin L; Brundin P
Neurobiol Dis; 2022 May; 166():105654. PubMed ID: 35143968
[TBL] [Abstract][Full Text] [Related]
26. Implications of In Vitro Multi-Serine Phosphorylation of Alpha-Synuclein in Aggregation and Cytotoxicity.
Chaturvedi M; Raj R; Yadav SK; Srivastava T; Devi S; Dharmadana D; Valéry C; Sharma SK; Kumar D; Priya S
ACS Chem Neurosci; 2023 Sep; 14(17):3103-3112. PubMed ID: 37562012
[TBL] [Abstract][Full Text] [Related]
27. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
28. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
[TBL] [Abstract][Full Text] [Related]
29. α-Synuclein in Parkinson's disease: causal or bystander?
Riederer P; Berg D; Casadei N; Cheng F; Classen J; Dresel C; Jost W; Krüger R; Müller T; Reichmann H; Rieß O; Storch A; Strobel S; van Eimeren T; Völker HU; Winkler J; Winklhofer KF; Wüllner U; Zunke F; Monoranu CM
J Neural Transm (Vienna); 2019 Jul; 126(7):815-840. PubMed ID: 31240402
[TBL] [Abstract][Full Text] [Related]
30. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A
Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728
[TBL] [Abstract][Full Text] [Related]
31. Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.
Longhena F; Faustini G; Spillantini MG; Bellucci A
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609739
[TBL] [Abstract][Full Text] [Related]
32. Alpha Synuclein: Neurodegeneration and Inflammation.
Forloni G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982988
[TBL] [Abstract][Full Text] [Related]
33. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
Oueslati A
J Parkinsons Dis; 2016; 6(1):39-51. PubMed ID: 27003784
[TBL] [Abstract][Full Text] [Related]
34. Spreading of alpha-synuclein between different cell types.
Ruf WP; Meirelles JL; Danzer KM
Behav Brain Res; 2023 Jan; 436():114059. PubMed ID: 35995264
[TBL] [Abstract][Full Text] [Related]
35. The Role of Lipids in the Initiation of α-Synuclein Misfolding.
Kiechle M; Grozdanov V; Danzer KM
Front Cell Dev Biol; 2020; 8():562241. PubMed ID: 33042996
[TBL] [Abstract][Full Text] [Related]
36. Generation of monoclonal antibodies against phosphorylated α-Synuclein at serine 129: Research tools for synucleinopathies.
Fayyad M; Majbour NK; Vaikath NN; Erskine D; El-Tarawneh H; Sudhakaran IP; Abdesselem H; El-Agnaf OMA
Neurosci Lett; 2020 Apr; 725():134899. PubMed ID: 32156613
[TBL] [Abstract][Full Text] [Related]
37. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.
O'Leary EI; Jiang Z; Strub MP; Lee JC
J Biol Chem; 2018 Jul; 293(28):11195-11205. PubMed ID: 29853639
[TBL] [Abstract][Full Text] [Related]
38. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
[TBL] [Abstract][Full Text] [Related]
39. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
40. Glutamatergic transmission and receptor expression in the synucleinopathy h-α-synL62 mouse model: Effects of hydromethylthionine.
Schwab K; Chasapopoulou Z; Frahm S; Magbagbeolu M; Cranston A; Harrington CR; Wischik CM; Theuring F; Riedel G
Cell Signal; 2022 Sep; 97():110386. PubMed ID: 35709886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
